Medicare Targets 15 Expensive Drugs for Price Cuts by 2028
Millions of Medicare patients will soon pay less for cancer treatments, HIV medications, and other essential drugs after 15 new medicines were selected for federal price negotiations. The new list includes the first physician-administered treatments ever chosen for these cost-cutting talks.